Bipolar Disorder

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no differences in (hypo)manic symptoms during active treatment but diverged during the post-treatment phase, with significantly higher (hypo)manic symp

Effect: decline; F(6,503)=3.38 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)

Bipolar adolescents with comorbid anxiety showed no difference in family conflict during active treatment but diverged in the post-treatment period, with significantly higher conflict by study end com

Effect: decline; F(6,383)=3.66 (anxiety x time interaction)